Halozyme Therapeutics, Inc. (HALO)
130.35
+1.73
(+1.35%)
USD |
NASDAQ |
Nov 04, 16:00
130.35
0.00 (0.00%)
After-Hours: 18:01
Halozyme Therapeutics Total Return Price : 130.35 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 128.62 |
| November 02, 2026 | 128.95 |
| October 30, 2026 | 130.91 |
| October 29, 2026 | 131.18 |
| October 28, 2026 | 130.03 |
| October 27, 2026 | 128.50 |
| October 26, 2026 | 128.01 |
| October 23, 2026 | 125.63 |
| October 22, 2026 | 124.54 |
| October 21, 2026 | 124.83 |
| October 20, 2026 | 124.37 |
| October 19, 2026 | 122.50 |
| October 16, 2026 | 121.84 |
| October 15, 2026 | 121.51 |
| October 14, 2026 | 116.82 |
| October 13, 2026 | 109.62 |
| October 12, 2026 | 111.08 |
| October 09, 2026 | 110.42 |
| October 08, 2026 | 109.84 |
| October 07, 2026 | 110.79 |
| October 06, 2026 | 109.72 |
| October 05, 2026 | 108.31 |
| October 02, 2026 | 109.86 |
| October 01, 2026 | 106.94 |
| September 30, 2026 | 110.40 |
| Date | Value |
|---|---|
| September 29, 2026 | 111.56 |
| September 28, 2026 | 112.89 |
| September 25, 2026 | 113.90 |
| September 24, 2026 | 115.22 |
| September 23, 2026 | 112.44 |
| September 22, 2026 | 115.13 |
| September 21, 2026 | 111.45 |
| September 18, 2026 | 112.45 |
| September 17, 2026 | 109.68 |
| September 16, 2026 | 108.44 |
| September 15, 2026 | 106.25 |
| September 14, 2026 | 107.94 |
| September 11, 2026 | 107.20 |
| September 10, 2026 | 107.00 |
| September 09, 2026 | 107.39 |
| September 08, 2026 | 108.31 |
| September 04, 2026 | 110.19 |
| September 03, 2026 | 110.76 |
| September 02, 2026 | 109.66 |
| September 01, 2026 | 107.72 |
| August 31, 2026 | 106.49 |
| August 28, 2026 | 105.35 |
| August 27, 2026 | 106.92 |
| August 26, 2026 | 107.06 |
| August 25, 2026 | 109.32 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| AVITA Medical, Inc. | 16.31 |
| Iovance Biotherapeutics, Inc. | 8.72 |
| Merck & Co., Inc. | 150.39 |
| Neurocrine Biosciences, Inc. | 166.09 |
| TG Therapeutics, Inc. | 61.64 |